#United States #Irvine #AbbVie #SkinMedica #Barrier Calming Cream

SkinMedica® Unveils Barrier Calming Cream

In an exciting development for skincare enthusiasts, Allergan Aesthetics, a subsidiary of AbbVie, has expanded its SkinMedica® product line with the introduction of the Barrier Calming Cream. This innovative moisturizer is engineered specifically to soothe and revitalize the skin, focusing on regeneration for healthier and more resilient skin.

The Barrier Calming Cream is created on two key components: the Calcium Strengthening Complex and the Botanical Calming Complex. These powerful ingredients work synergistically to address various skin concerns, especially the vital need to support and protect the skin barrier, which is increasingly becoming a priority among today's consumers.

The Importance of Skin Barrier Health

Recent trends suggest that 70% of skincare users in the United States are now more vigilant about protecting their skin barrier than they were just a year ago. This growing awareness underscores the significant role that a strong skin barrier plays in maintaining overall skin health. Nicole Mowad-Nassar, Senior Vice President at AbbVie and President of Global Allergan Aesthetics, highlights that SkinMedica has been at the forefront of the regenerative skincare movement, and the launch of this product is a testament to their commitment to science-driven skincare solutions.

Key Ingredients and Benefits

1. Barrier Restoration: The Calcium Strengthening Complex plays a crucial role not only in bone health but also in restoring and balancing the skin barrier, especially under stress.
2. Instant Calm: The inclusion of Mondo grass root in the Botanical Calming Complex is known for its ability to reduce visible redness while enhancing the skin’s tolerance to harsh chemicals and ingredients.
3. Lasting Hydration: Formulated to lock in moisture, the cream replenishes natural lipids to prevent dryness. Clinical studies have shown a remarkable 30% reduction in skin dryness just two weeks after use.

Prithwiraj Maitra, Ph.D., Vice President of Global Skincare Research and Development at Allergan Aesthetics, emphasizes the need for a healthy skin barrier, stating, “When the barrier is compromised, even the most effective ingredients fail to perform optimally.”

Additional Launch: HA5® Hydra Collagen Facial Mist

In conjunction with the Barrier Calming Cream, SkinMedica is also introducing the HA5® Hydra Collagen Facial Mist, which features vegan collagen. This ultra-fine mist is versatile enough to be applied over makeup and sunscreen without leaving a residue, making it an ideal product for hydration on the go. Clinical tests reveal a staggering 31% increase in skin hydration with just one application, further enhancing the comprehensive skincare routine.

Both the SkinMedica® Barrier Calming Cream, priced at $140, and the HA5® Hydra Collagen Facial Mist, retailing at $58, can be purchased through SkinMedica.com as well as via licensed medical professionals and supervised spas.

As Allergan continues to innovate and respond to the demands of skincare consumers, SkinMedica® can be expected to play a crucial role in advancing skincare technology that meets the diverse needs of skin health.

For more information and updates, follow SkinMedica on social media @SkinMedica.

Conclusion

The launch of the Barrier Calming Cream represents more than just a new product; it's a movement towards understanding and enhancing skin barrier health. As skincare routines evolve, products like these that emphasize barrier protection will likely become staples in daily regimens, promising better, healthier skin for all.

• ---

About Allergan Aesthetics: As part of AbbVie, Allergan Aesthetics is dedicated to providing leading aesthetics products and fostering innovation in both service and ethics. For further details, visit Allergan Aesthetics.

About AbbVie: AbbVie is committed to discovering and delivering transformative medicines to address complex health conditions. Their focus spans across several therapeutic areas, emphasizing an impact on patients’ well-being. To explore further, visit AbbVie.